Clinical significance of urinary liver-type fatty acid binding protein at various stages of nephropathy

por Viswanathan, V., Sivakumar, S., Sekar, V., Umapathy, D., Kumpatla, S.
Publicado 2015

Pharmacokinetic (PK) and pharmacodynamic analyses of once- and twice-daily darunavir/ritonavir (DRV/r) in the ODIN trial

por Sekar, V, De La Rosa, G, Van de Casteele, T, Spinosa-Guzman, S, Vis, P, Hoetelmans, RMW
Publicado 2010